Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.705 USD | -2.50% | +1.36% | -9.90% |
05-08 | Transcript : Relmada Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Relmada Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.90% | 115M | |
+3.25% | 108B | |
+11.16% | 104B | |
+1.28% | 22.33B | |
-12.78% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.62% | 17.64B | |
+4.29% | 14.05B | |
+34.84% | 12.51B |
- Stock Market
- Equities
- RLMD Stock
- News Relmada Therapeutics, Inc.
- Truist Securities Downgrades Relmada Therapeutics to Hold From Buy, Adjusts Price Target to $10 From $90